Boundless Bio, Inc.

BOLD · Nasdaq · SIC 2834: Pharmaceutical Preparations
27
SEC Filings

Business Summary

4 Item 1A. Risk Factors 40 Item 1B. Unresolved Staff Comments 88 Item 1C. Cybersecurity 88 Item 2. Properties 89 Item 3. Legal Proceedings 89 Item 4. Mine Safety Disclosures 90 PART II Item 5. Market for Registrants Common Equity, Related Stockholder Matters, and Issuer Purchases of Equity Securities 91 Item 6. [Reserved] 91 Item 7. Managements Discussion and Analysis of Financial Condition and Results of Operations 92 Item 7A. Quantitative and Qualitative Disclosures About Market Risk 102 Item ...

Next Earnings

Q2 FY2026 — expected 2026-08-11

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionBOLDdiscussed_in_filing Cybersecurity
topic_mentionBOLDdiscussed_in_filing Cybersecurity
topic_mentionBOLDdiscussed_in_filing Cybersecurity
topic_mentionBOLDdiscussed_in_filing Cybersecurity

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-092025-12-310001193125-26-097543EDGAR95K words
2025-03-272024-12-310000950170-25-045725EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-052025-09-300001193125-25-265714EDGAR31K words
2025-08-052025-06-300000950170-25-102391EDGAR—
2025-05-092025-03-310000950170-25-067496EDGAR—
2024-11-072024-09-300000950170-24-123291EDGAR—
2024-08-122024-06-300000950170-24-095421EDGAR—
2024-05-132024-03-310000950170-24-058188EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-03-090001193125-26-097535EDGAR2K words
2025-11-050001193125-25-265707EDGAR—
2025-08-050000950170-25-102386EDGAR—
2025-06-230000950170-25-089002EDGAR—
2025-05-230000950170-25-076911EDGAR—
2025-05-090000950170-25-067495EDGAR—
2025-04-010001193125-25-070496EDGAR—
2025-03-270000950170-25-045722EDGAR—
2024-12-120000950170-24-135768EDGAR—
2024-11-070000950170-24-123274EDGAR—

27 total filings indexed. 9 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Company Identity

CIK0001782303
TickerBOLD
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedDE

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 4231905b453fe6f3a81d49b310538c1ac9b0be0ee453491dd92900a62d8f605d
parent: fb3317ead322382279f5779d9ecb69130759ebc3fb5cfba13b24bafb2d5cda01
content hash: 8223074d1062b7d3b272a71365e8809b604eb28254675ff654ca2bf628155b30
signed: 2026-04-13T04:44:03.568Z
sources: 8 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf